ArticleLiver cancer2020

Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis.

Yusuke Kawamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.